|
|
||||||||
RIIb in B Cells1



Departments of
*
Microbiology and
Internal Medicine, Ohio State University, OH 43210; and
Affinity Sensors, Franklin, MA 02038
| Abstract |
|---|
|
|
|---|
RIIb. In addition, we reported that
SHIP-Shc interaction involves both SHIP SH2 and Shc phosphotyrosine
binding domains. These findings reveal a paradox in which the single
SH2 domain of SHIP is simultaneously engaged to two different proteins:
Shc and Fc
RIIb. To resolve this paradox, we examined the protein
interactions of SHIP. Our results demonstrated that isolated Fc
RIIb
contains SHIP but not Shc; likewise, Shc isolates contain SHIP but not
Fc
RIIb. In contrast, SHIP isolates contain both proteins, revealing
two separate pools of SHIP: one bound to Fc
RIIb and one bound to
Shc. Kinetic studies reveal rapid SHIP association with Fc
RIIb but
slower and more transient association with Shc. Affinity measurements
using a recombinant SHIP SH2 domain and phosphopeptides derived from
Fc
RIIb (corresponding to Y273) and Shc (corresponding to Y317)
revealed an approximately equal rate of binding but a 10-fold faster
dissociation rate for Fc
RIIb compared with Shc phosphopeptide and
yielding in an affinity of 2.1 µM for Fc
RIIb and 0.26 µM for
Shc. These findings are consistent with a model in which SHIP
transiently associates with Fc
RIIb to promote SHIP phosphorylation,
whereupon SHIP binds to Shc and dissociates from
Fc
RIIb. | Introduction |
|---|
|
|
|---|
isoform of phospholipase C, stimulation of phosphatidylinositol
(PtdIns) 3-kinase, and induction of the Ras pathway (1). The Ras
pathway is presumably important for B cell proliferation, although
there is no direct information in B cells in this regard.
Induction of the Ras pathway by sIg, similar to other receptors,
involves phosphorylation of sIg-associated proteins Ig
and Igß on
tyrosine residues within the conserved immunoreceptor tyrosine-based
activation motif (ITAM) (reviewed in Refs. 2 and 3). ITAM
phosphorylation leads to recruitment of the adapter protein Shc via its
Src homology 2 (SH2) domain that in turn promotes Shc phosphorylation
at tyrosine residues 239, 240 (4), and 317 (5, 6). Phosphorylation at
these residues creates an optimal binding site for the SH2 domain of
the adapter protein Grb2 (6) and the SH2 domain-containing inositol
phosphatase (SHIP) (7, 8). Recent reports of B cell signal
transduction indicated that, concomitant with the above events, Grb2
association with the Ras exchange factor Sos is also enhanced (9).
Translocation of Sos to the sIg signaling complex at the plasma
membrane through these protein interactions appears to catalyze
GTP binding to Ras (10) and is rate-limiting for Ras activation.
SH2 domains act as independent protein interaction modules and bind to a tyrosine phosphorylated residue within a larger target protein (reviewed in Refs. 1113). The SH2-phosphotyrosine interaction is modified and specified by residues in the +1 to +3 position, C terminal to the phosphorylated tyrosine residue of the interaction target. Thus, while the phosphorylated ITAM motif presents an optimal binding site for the SH2 domain of Shc (14), the same phosphorylated ITAM is incapable of binding to the SH2 domain of SHIP (15).
Co-cross-linking the B cell IgG receptor, Fc
RIIb, to sIg blocks B
cell activation in a process termed "negative" signaling and
opposed to "positive" signaling of sIg cross-linking alone. Our
recent studies indicated that negative but not positive signaling
conditions promoted tyrosine phosphorylation of SHIP and its
interaction with Shc (16). To date, SHIP and Fc
RIIb are the only
proteins known to be tyrosine phosphorylated exclusively under
conditions of negative signaling. Further studies revealed an essential
role for Fc
RIIb expression in the induction of SHIP phosphorylation
under negative signaling conditions (15, 17). Thus, these experiments
indicated that SHIP was recruited to the phosphorylated ITAM-like
immunoreceptor tyrosine-based inhibitory motif (ITIM; ITYSLL; reviewed
in Refs. 2 and 3) through its N-terminal SH2 domain. We further
observed that ITIM recruitment of SHIP was necessary for SHIP
phosphorylation on tyrosine and its interaction with Shc (15).
At the same time, SHIP interacts with the adapter protein Shc and this interaction is limited by SHIP but not Shc phosphorylation. We (8) and others (7) have demonstrated that SHIP-Shc interaction is bidentate, such that the phosphotyrosine-binding domain (PTB) of Shc interacted with either of two NPxY motifs within SHIP (including SHIP residues Y931 and Y1035, respectively) and the SH2 domain of SHIP bound phosphorylated Shc at Tyr317 and doubly phosphorylated tyrosines 239/240. We have further proposed (18, 19) that SHIP SH2 engagement by phosphorylated Shc competes with and ultimately precludes an interaction of Grb2 SH2 with phosphorylated Shc, thereby accounting for the observed inhibition of the Ras pathway in B cells stimulated under negative signaling conditions (18, 19, 20).
Together, these findings from several laboratories reveal a paradox in
which the single SH2 domain of SHIP is simultaneously engaged to two
different proteins: Fc
RIIb and Shc. To address this issue, we have
analyzed protein interactions of SHIP and Shc in B cells stimulated
under negative signaling conditions of sIg-Fc
RIIb co-cross-linking.
Unlike mast cells responding to IL-3 (21), we did not detect
SHP-2 associated with SHIP; rather, SHIP was associated with two
phosphoproteins: Shc and Fc
RIIb. However, Shc precipitates do not
contain Fc
RIIb; likewise, Fc
RIIb precipitates do not display Shc.
Experiments on the association kinetics indicated that SHIP binds
Fc
RIIb very early, within 30 s of stimulation, and this
association is maintained for several minutes. In contrast, SHIP
association with Shc appeared later and was shorter-lived. The data
argue for two separate and distinct pools of SHIP, one bound to
Fc
RIIb and another bound to Shc. Affinity measurements using the
recombinant SH2 domain of SHIP indicated transient and lower affinity
binding to a phosphopeptide corresponding to Y273 of murine Fc
RIIb
but stable and higher affinity binding to a phosphorylation site of
Shc. We propose a model in which SHIP transiently associates with
Fc
RIIb to promote SHIP phosphorylation, whereupon it disengages
Fc
RIIb and stably associates with phosphorylated Shc. These novel
findings regarding the affinity of the SH2 domain of SHIP and Shc for
their interaction partners and the kinetics of their association
account for several unusual features of negative signaling. In
addition, the rank order of affinities among Fc
RIIb, SHIP, Shc and
Grb2 reveal a system optimally designed to turn on and off B cell
sIg-mediated signal transduction.
| Materials and Methods |
|---|
|
|
|---|
F(ab')2 fragments and whole molecule of rabbit
anti-mouse IgG Ab were obtained from Cappel Research Products
(Durham, NC); other immunoprecipitating and immunoblotting Abs were
from Upstate Biotechnology (Lake Placid, NY). Anti-SHIP Ab was
generated using a glutathione S-transferase (GST) fusion
protein of SHIP residues 874941, obtained by PCR amplification of
SHIP cDNA, as described earlier (15). The purified protein was injected
into rabbits and tested by immunoblot and immunoprecipitation. Protein
G-agarose was purchased from Life Technologies/BRL (Gaithersburg, MD);
glutathione-agarose was from Sigma (St. Louis, MO); and the enhanced
chemiluminescence kit was from Kirkegaard & Perry (Gaithersburg, MD).
A20 murine B cells were obtained from the American Type Culture
Collection (Manassas, VA). The Fc
R-deficient cell line was a gift
from I. Mellman (Yale University, New Haven, CT). GST-Grb2 fusion
protein was obtained from Dr. Andreas Kazlauskas (National Jewish
Hospital, Denver, CO). Prevanadate was generated by mixing 3 mM
Na3VO4 with 1.5% H2O2;
10 x 106 cells in 100 µl were stimulated with 10
µl of the mixture.
Lysis, immunoprecipitation, and immunoblotting
Cell lysis, immunoprecipitation, and immunoblotting were performed as previously described (16). Briefly, B cells were stimulated with 10 µg/ml F(ab')2 fragment or whole molecule of rabbit anti-mouse IgG for the indicated times at 37°C and lysed with TN1 buffer (50 mM Tris (pH 8.0), 10 mM EDTA, 10 mM Na4P2O7, 10 mM NaF, 1% Nonidet P-40, 125 mM NaCl, 10 mM Na3VO4, and 10 µg/ml each aprotinin and leupeptin). Postnuclear extracts were incubated overnight with the Ab of interest followed by protein G-agarose. Samples were washed with lysis buffer and resuspended in SDS sample buffer (60 mM Tris (pH 6.8), 2.3% SDS, 10% glycerol, 0.01% bromphenol blue). Precipitated proteins were separated by SDS-PAGE, transferred to nitrocellulose filters, probed with the Ab of interest, and developed by enhanced chemiluminescence. In some cases, filters were stripped of primary Ab as described earlier (8, 15), washed, and reprobed.
GST in vitro binding assay
SHIP was immunoprecipitated from resting and activated A20
lysates with anti-SHIP antisera, collected with protein G-agarose
and the sample was divided into two aliquots. One half was
reprecipitated with 100 nM GST-Grb2 fusion protein to obtain
SHIP-associated, phosphorylated Shc. The protein complexes were
collected as previously described (8, 15) with glutathione-agarose
beads, washed three times with lysis buffer, resuspended in SDS sample
buffer, and separated by 10% SDS-PAGE. The separated proteins were
transferred to nitrocellulose and analyzed by immunoblotting with
anti-Shc. The anti-Shc Ab is a rabbit polyclonal sera made
against a GST-Shc fusion protein and thus is immunoreactive with
GST-Grb2. The other half was resolved by 10% SDS-PAGE and
immunoblotted with antiphosphotyrosine to detect SHIP-associated p62
Fc
RIIb.
Deglycosylation of Fc
R
Fc
R from activated A20 cells was captured with human
IgG-Sepharose using human IgG covalently attached to Sepharose at 10
mg/ml packed beads or in anti-SHIP immunoprecipitates. The bound
protein was eluted from the beads with 20 µl of 0.7% SDS. The eluate
was split in half, and one half was treated with endoglycosidase F
(Boehringer Mannheim, Indianapolis, IN; 20 U/100 µl); the
other half was mock-treated with enzyme diluent. The reaction mixtures
were incubated overnight at 37°C, and 5 volumes of cold acetone was
added to each sample for 15 min at -20°C to precipitate protein. The
samples were spun at 14,000 rpm for 10 min and precipitated proteins
were redissolved in SDS sample buffer, run on 10% SDS-PAGE,
transferred to nitrocellulose membrane, and probed with
antiphosphotyrosine Ab.
Affinity measurements of the SHIP SH2 domain for phosphopeptides
Synthetic N-terminally biotinylated phosphopeptides
corresponding to Y273 of the murine Fc
RIIb (containing the ITIM
motif) and to Y317 of human Shc were purchased from Quality Controlled
Biochemicals (Torrence, CA) and were generated as earlier described
(8). Both of these peptides were shown to directly bind the SHIP SH2
domain and to compete with the binding of the endogenous proteins to
SHIP (8). GST fusion protein encoding the SH2 domain of SHIP was
generated as previously described (15). Peptides were immobilized in
the two sensor cells of a planar biotin cuvette for use on an IAsys
evanescent-wave optical biosensor according to the manufacturers
protocol (IAsys; Affinity Sensors, Cambridge, U.K.). Briefly, the
sensor surfaces bearing biotin were covered with a 2-min application of
5 mg/ml neutravidin (Pierce, Rockford, IL). The excess neutravidin was
washed out with 10 mM PBS (pH 7.4) with 0.05% Tween 20 (binding
buffer). Free biotin-binding sites were saturated with an excess of
biotinylated peptide in each cell, giving signals of 16 and 30 arc s of
immobilized Shc and Fc
RIIb peptides, respectively. Biotin cuvettes
were completely regenerated by a 1-min exposure to 12 M KOH followed by
copious buffer washing; surfaces were then reloaded with the same
amount of neutravidin and biotinylated peptide for further analysis.
Kinetic experiments were performed using the pseudo-first order
approach outlined in the IAsys user documentation. Measurements were
made at 22°C, with the stirrer speed set at 100% of maximum and data
collection at 0.3 s per data point. For successive binding cycles,
varying amounts of stock GST-SHIP SH2 domain were diluted into binding
buffer to initiate binding (arrow 1 in Fig. 5
). Real-time rate data
were collected for 35 min, then the cuvette cells were washed twice
with 100-µl aliquots of fresh running buffer to commence collection
of dissociation rate data (arrow 2 in Fig. 5
). At the end of the 3- to
5-min dissociation period, the surface was regenerated with 3 M
MgCl2. Preliminary controls were performed to establish
that GST-SHIP SH2 domain did not bind at all to the neutravidin
platform lacking peptide (Fig. 5
A, curve C). Initial (first
2040 s) binding rates for each peptide at each GST-SHIP SH2 domain
concentration were fitted using FASTfit software (Affinity Sensors) by
nonlinear regression analysis to a simple monophasic binding equation:
R = Req [1 -
exp(-kont)], where the amount of
GST-SHIP SH2 domain bound (R) at time (t)
is some fraction of the final level bound at equilibrium
(Req) as a function of the observed binding rate
(kon) at the concentration of GST-SHIP SH2
domain present after injection. Second-order association rate constants
(kass) and dissociation rate constants
(kdiss) were inferred from the slope and
y-intercept of those plots, respectively. Dissociation rates
were also measured by direct fitting of dissociation data and found to
be comparable to y-intercepts-derived values to within
error. Initial kinetics were used to simplify biosensor data sets that
revealed secondary, later-occurring kinetic behavior that was
attributed to self-association of GST domains. Efficient thrombin
cleavage of GST domains was not possible.
|
| Results |
|---|
|
|
|---|
|
RIIb (15, 22); both interactions involve the
SHIP SH2 domain. Although the protein core of Fc
RIIb is
40 kDa,
the mature protein migrates with an apparent molecular mass of
45 kDa (22) to 60 kDa (23, 24). The variability in apparent m.w. is
likely due to differential glycosylation in different cells, although
Fc
RIIb from the A20 murine B cell lymphoma line used in these
experiments has been reported as a 45-kDa (25) to a 60-kDa (23)
protein. To assess whether the SHIP-associated p62 protein was either
phospho-Shc or Fc
RIIb, B cells were stimulated with pervanadate and
immunoprecipitated with Abs to Shc, SHIP (rabbit polyclonal antisera)
or Fc
RIIb (2.4G2 mouse mAb) and the resulting samples were
immunoblotted with antiphosphotyrosine. The results, shown in Fig. 2
RIIb immunoprecipitates. The same three
tyrosine-phosphorylated proteins (p145SHIP, p62, and p52Shc) were found
in SHIP immunoprecipitates of pervanadate-stimulated A20 lymphoma and
primary splenic B cells (Fig. 2
RIIb which is tyrosine phosphorylated by
pervanadate treatment (Fig. 2
|
RIIb, the B cell
line A20 or the Fc
RIIb-deficient A20 derivative IIA1.6 were
stimulated with intact anti-Ig to induce co-cross-linking of sIg
and Fc
RIIb. The cells were lysed in detergent and the lysates were
immunoprecipitated with Abs to Shc or SHIP. The immunoblot results
shown in Fig. 2
RIIb-deficient IIA1.6 B cells. As above, p62 was apparent in SHIP
but not Shc immunoprecipitates.
Because there is no immunoblotting reagent that specifically detects
the core protein of murine Fc
RII, we used two additional approaches
to test the possibility that p62 represents murine Fc
RII. First, we
affinity-adsorbed all IgG receptors from detergent lysates of
pervanadate-stimulated A20 B cells using normal human IgG-coated
Sepharose. Second, we obtained p62 associated with SHIP by subjecting
A20 B cells stimulated with intact anti-Ig with Abs to SHIP. The
bound material from both samples was deglycosylated with
endoglycosidase F, separated by SDS-PAGE, and probed with
antiphosphotyrosine Abs after transfer to filters. The results (Fig. 2
D) demonstrated that IgG-Sepharose or anti-SHIP
coprecipitates a tyrosine-phosphorylated p62 protein that, upon
deglycosylation, migrates at
40 kDa, similar to the reported core
protein of Fc
RIIb (26, 27). Together, these findings strongly
support the hypothesis that p62 represents a highly glycosylated form
of Fc
RIIb in A20 B cells.
Results in these experiments revealed both Shc and p62 Fc
RIIb in
SHIP immunoprecipitates (Fig. 2
A, lane 4, and
Fig. 2
B, lane 8). Likewise, SHIP was found in
immunoprecipitates of Shc, indicating these two proteins inducibly
associate, as earlier reported (7, 8, 16). In contrast, we did not
observe the presence of p62 Fc
RIIb in Shc immunoprecipitates (Fig. 2
A, lane 2, and Fig. 2
C, lane
6), suggesting that Fc
RIIb does not associate with Shc, either
directly through the SH2 domain of Shc or indirectly through SHIP. If
so, this observation implies that SHIP dissociates from the ITIM motif
of Fc
RIIb upon binding to Shc, although it is not clear how or why
dissociation would occur.
To more rigorously test the possibility that Shc is excluded from
tyrosine-phosphorylated Fc
RIIb, immunoprecipitates of Shc or
Fc
RIIb from resting or pervanadate-stimulated A20 B cells were
probed with Abs to phosphotyrosine or to Shc. The antiphosphotyrosine
blots (Fig. 3
, top) revealed
tyrosine-phosphorylated p52 and p46 Shc in the anti-Shc but not the
Fc
RIIb immunoprecipitates. Probing the same samples with
anti-Shc Abs demonstrated that Shc was not detected in Fc
RIIb
immunoprecipitates, consistent with data in Fig. 2
A showing
that Fc
RIIb was absent from Shc immunoprecipitates. Thus, we
observed the activation-induced formation of two distinct complexes,
one containing SHIP-Shc and another containing SHIP-Fc
RIIb but not
one that includes Shc-Fc
RIIb. These findings then specifically
exclude a heterotrimeric complex that would include all three proteins.
|
RIIb, becomes phosphorylated and dissociates from Fc
RIIb upon
binding to Shc. To test this possibility, we measured the kinetics of
association of SHIP to Fc
RIIb and of SHIP to Shc. For these
experiments, A20 B cells were stimulated under negative signaling
conditions with intact rabbit anti-mouse Ig at different times,
then lysed and subjected to immunoprecipitation with anti-SHIP. The
immune complexes were isolated and proteins were eluted with SDS sample
buffer. One half of the eluate was then diluted in lysis buffer and
reprecipitated with GST-Grb2 to pull down phosphorylated Shc, as we
earlier described (18) and to prevent the interference of the Ig heavy
chain. These samples were immunoblotted with anti-Shc Ab while the
other half was probed with antiphosphotyrosine to detect p62 Fc
RIIb.
The antiphosphotyrosine blots, shown in Fig. 4
RIIb within 30 s of stimulation, was maximal
within 60 s, and that the association was maintained over the
entire stimulation period of 12 min. In contrast, SHIP association with
Shc (Fig. 4
RIIb and
Shc are consistent with the hypothesis mentioned above that Shc binding
to phospho-SHIP induces SHIP dissociation from Fc
RIIb, although the
kinetic results likewise do not suggest an immediately obvious
mechanism for this to occur.
|
RIIb and is
essential for phosphorylation of the NPxY motifs (15). The apparent
lack of a stable trimeric complex between Fc
RIIb-SHIP-Shc indicates
that SHIP disengages Fc
RIIb upon Shc PTB domain binding. A possible
explanation for SHIP disengagement and re-engagement of Fc
RIIb and
Shc, respectively, is that the intrinsic affinity of the SH2 domain of
SHIP is greater for phospho-Shc than for phospho-Fc
RIIb. According
to this possibility, upon Shc PTB engagement of SHIP, the SHIP SH2
domain releases Fc
RIIb and engages phospho-Shc. To examine this
issue, we applied the SH2 domain of SHIP to biotinylated, immobilized
phosphopeptides corresponding to the ITIM motif of Fc
RIIb
(pITIM) or of Y317 in Shc (pYVNV); both of these peptides
were earlier shown to engage the SH2 domain of SHIP (8, 15), whereas
the Shc Y317 phosphopeptide bound with high affinity to the SH2 domain
of Grb2 (7). Kinetic properties of the interaction between
biotinyl-pITIM and biotinyl-pYVNV peptides were determined using
an evanescent-wave optical biosensor (IAsys Auto+Advantage, Affinity
Sensors). In this assay, the biotin linked to the sensor surfaces was
coated with tetrameric neutravidin, which in turn captured comparable
quantities of biotinylated peptides. The recombinant GST-SHIP SH2
domain was added at varying concentrations to the 80 µl cuvette
cells. Resulting SHIP binding and dissociation profiles are compared
for a single SHIP SH2 domain concentration in Fig. 5
RIIb compared with
phospho-Shc and represents the essential difference between the two
affinities. Thus, although GST-SHIP SH2 domain binds to both peptides
at approximately the same rate, it dissociates
10-fold more rapidly
from the Fc
RIIb pITIM than from Shc pYVYV, resulting in an
10-fold greater overall affinity of Shc pYVNV (2.1 µM) than pITIM
of Fc
RIIb (0.26 µM) in binding the SH2 domain of SHIP. The kinetic
and equilibrium constants determined for the SH2 domain of SHIP binding
to both phosphopeptides and derived from this analysis is shown in Fig. 5| Discussion |
|---|
|
|
|---|
RIIb and
there are no detectable amounts of either SHP-2 or SHP-1 in these
immunoprecipitates. Likewise, we failed to detect a 72-kDa
tyrosine-phosphorylated Syk candidate protein in SHIP
immunoprecipitates, although we have not specifically examined such
samples for the presence of the Syk tyrosine kinase.
We had earlier observed a 62-kDa tyrosine-phosphorylated protein
associated with SHIP (15), whereas we (15) and others (22) have
described association of SHIP to the B cell IgG receptor, Fc
RIIb.
The precise molecular mass of Fc
RIIb has been reported with varying
molecular masses, partly due to differences in glycosylation from cell
to cell but also due to the lack of a definitive immunoblotting
reagent. Findings described here establish that the SHIP-associated p62
represents Fc
RIIb from A20 because p62 is absent from
Fc
RIIb-deficient B cells (Fig. 2
C), becuse p62 comigrates
with phosphorylated Fc
RIIb obtained using the established
immunoprecipitating monoclonal anti-Fc
RIIb Ab, 2.4G2 (Fig. 2
A), and because deglycosylated p62 migrates with a core
protein size of
40 kDa, the predicted molecular mass of Fc
RIIb
(Fig. 2
B).
In the course of identifying p62, we observed that p62 Fc
RIIb was
absent in Shc immunoprecipitates and that Shc was absent in Fc
RIIb
immunoprecipitates, whereas SHIP immunoprecipitates contained both Shc
and Fc
RIIb. Thus, the three proteins do not form a stable,
heterotrimeric complex of p62-SHIP-Shc, but do form heterodimeric
complexes of p62 Fc
RIIb-SHIP and SHIP-p52 Shc, and these complexes
are stable because they survive coimmunoprecipitation. The two pools of
SHIP are therefore exclusive, but may represent transitional forms such
that one is converted to another during the course of stimulation.
SHIP association with Fc
RIIb is consistent with earlier reports that
the SH2 domain of SHIP associates with the phosphorylated ITIM motif of
Fc
RIIb (15). Likewise, SHIP association with Shc is consistent with
observations that the Shc PTB domain interacts with phosphorylated SHIP
and that the SHIP SH2 domain binds phosphorylated Shc (7, 8), although
alternative views regarding the role of SHIP SH2 domain in its
interaction with Shc have been reported (37). Nevertheless,
observations invoking a role for the SHIP SH2 domain in SHIP-Shc
interaction raise a paradox wherein the single SH2 domain of SHIP is
concomitantly bound to two different proteins: Fc
RIIb and Shc.
One possible explanation for this paradox is that the SH2 domain of
SHIP has greater affinity for phospho-Shc than for phospho-Fc
RIIb.
According to this model, SHIP weakly engages phosphorylated Fc
RIIb
and acquires phosphorylated tyrosine residues. The Shc PTB domain is
then engaged, bringing phosphotyrosines of Shc within range of the SH2
domain of SHIP. Because of the intrinsically higher affinity, the SH2
domain of SHIP releases Fc
RIIb and binds to phospho-Shc. This
hypothesis accounts for the existence of two mutually exclusive pools
of SHIP, one pool transiently bound to Fc
RIIb and one pool stably
bound to Shc. In addition, this hypothesis accounts for our findings
regarding SHIP-protein interaction kinetics, shown in Fig. 4
, in which
SHIP engages p62 Fc
RIIb early during negative signaling and later
binds p52 Shc.
Direct measurements of the intrinsic affinity of the SHIP SH2 domain
revealed a 10-fold difference in the overall affinity between
phospho-ITIM of Fc
RIIB and phospho-Shc. However, the lower affinity
of the ITIM motif was due not to a reduced rate of association but
rather to an accelerated rate of dissociation, relative to phospho-Shc.
This intriguing observation indicates that phosphorylated Fc
RIIb
rapidly associates with the SH2 domain of SHIP to promote its tyrosine
phosphorylation and rapidly dissociates to permit its interaction with
Shc.
Based on the observations reported here, we have formulated a model
shown in Fig. 6
. Early in negative
signaling, the SH2 domain of SHIP is engaged to the phospho-ITIM motif
of Fc
RIIb, necessary for SHIP tyrosine phosphorylation as well as
for the subsequent interaction with Shc. Upon SHIP tyrosine
phosphorylation, the Shc PTB engages either or both of the NPxpY motifs
within SHIP. The interaction with the Shc PTB domain may raise the
local concentration of the phosphorylated tyrosine residues within Shc,
with its intrinsically higher affinity, thereby promoting the SH2
domain of SHIP to release Fc
RIIb and bind Shc. This new model
accounts for several earlier and unusual observations regarding SHIP in
B lymphocytes. First, the tyrosine phosphorylation of SHIP is much
greater under conditions of negative signaling (16). This fact is
likely due to the relatively weak affinity of the SH2 domain of SHIP
for phospho-ITIM of Fc
RIIb, exclusively phosphorylated under
negative signaling conditions due to coclustering with sIg-associated
protein tyrosine kinases. Phospho-ITIM recruitment of SHIP as a
prerequisite for its phosphorylation is consistent with our earlier
genetic studies (15). Second, SHIP associates with Shc only under
negative signaling conditions; i.e., there is minimal interaction
between these two proteins under positive signaling conditions, despite
the fact that Shc is highly phosphorylated and the SH2 domain of SHIP
displays affinity for phospho-Shc (7, 8, 16). This observation is
likely due to the relatively higher affinity of the Grb2 SH2 domain for
phospho-Shc, as compared with that of the SHIP SH2 domain (7). Thus,
Shc phosphorylation in the absence of SHIP phosphorylation favors
Shc-Grb2 interaction rather than Shc-SHIP interaction. Third, Shc and
Grb2 do not form a stable complex under negative signaling conditions,
despite the relatively higher affinity of Grb2 for phospho-Shc (18).
However, SHIP-Shc complexes are readily apparent under negative but not
positive signaling (16, 18). These earlier findings in conjunction with
the affinity and kinetic data reported here indicate that the formation
of a stable SHIP-Shc interaction complex requires SHIP tyrosine
phosphorylation and interaction through the PTB domain of Shc. The
added contribution of the PTB domain of Shc binding to phospho-SHIP,
along with the SH2 domain of SHIP engaging phospho-Shc, generates a
stable, bidentate complex and one in which the SH2 domain of SHIP can
successfully compete, despite its lower affinity, with that of Grb2 for
binding to Shc (19) to block the Ras pathway. The system, with its
hierarchy of affinities between the various interacting partners,
dynamically modulated by phosphorylation of the Fc
RIIb ITIM, is thus
optimally designed to inhibit B cell activation during negative but not
positive signaling.
|
| Footnotes |
|---|
2 S.T. and M.P. have contributed equally to this work. ![]()
3 Address correspondence and reprint requests to Dr. K. Mark Coggeshall, Department of Microbiology, Ohio State University, 484 West 12th Avenue, Columbus, OH 43210. E-mail address: ![]()
4 Abbreviations used in this paper: sIg, surface immunoglobulin; GST, glutathione S-transferase; ITAM, immunoreceptor tyrosine-based activation motif; ITIM, immunoreceptor tyrosine-based inhibitory motif; PTB, phosphotyrosine-binding; PtdIns, phosphatidylinositol; SH2, Src homology 2; SHIP, SH2 domain-containing inositol phosphatase; SHP-2, SH2 domain-containing phosphotyrosine phosphatase-2. ![]()
Received for publication August 11, 1998. Accepted for publication October 26, 1998.
| References |
|---|
|
|
|---|
ITIM peptide motif. Mol. Cell. Biol. 17:4305.[Abstract]
RIIB1 and is tyrosine phosphorylated during "negative" signaling. Immunol. Lett. 54:77.[Medline]
receptors inhibit B cell activation by interacting with the p21(ras)-dependent pathway. J. Biol. Chem. 271:30499.
RIIB. Nature 383:263.[Medline]
RIIB-mediated inhibition of B cell antigen receptor activation. J. Biol. Chem. 272:20038.
RIIB1. Science 268:293.
R genes: duplication and recombination. Science 248:732.
activates Brutons tyrosine kinase in concert with Src family kinases. Proc. Natl. Acad. Sci. USA 94:13820.This article has been cited by other articles:
![]() |
L. A. Kamen, J. Levinsohn, and J. A. Swanson Differential Association of Phosphatidylinositol 3-Kinase, SHIP-1, and PTEN with Forming Phagosomes Mol. Biol. Cell, July 1, 2007; 18(7): 2463 - 2472. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yogo, M. Mizutamari, K. Mishima, H. Takenouchi, N. Ishida-Kitagawa, T. Sasaki, and T. Takeya Src Homology 2 (SH2)-Containing 5'-Inositol Phosphatase Localizes to Podosomes, and the SH2 Domain Is Implicated in the Attenuation of Bone Resorption in Osteoclasts Endocrinology, July 1, 2006; 147(7): 3307 - 3317. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Wani, L. D. Haynes, J. Kim, C. L. Bronson, C. Chaudhury, S. Mohanty, T. A. Waldmann, J. M. Robinson, and C. L. Anderson Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant beta2-microglobulin gene PNAS, March 28, 2006; 103(13): 5084 - 5089. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Sharma, H.-S. Son, S. Ugi, W. Ricketts, and J. M. Olefsky Mechanism of SHIP-Mediated Inhibition of Insulin- and Platelet-Derived Growth Factor-Stimulated Mitogen-Activated Protein Kinase Activity in 3T3-L1 Adipocytes Mol. Endocrinol., February 1, 2005; 19(2): 421 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Hunter, A. Jacob, L. C. O'Donnell, A. Agler, L. J. Druhan, K. M. Coggeshall, and B. R. Avalos Loss of SHIP and CIS Recruitment to the Granulocyte Colony-Stimulating Factor Receptor Contribute to Hyperproliferative Responses in Severe Congenital Neutropenia/Acute Myelogenous Leukemia J. Immunol., October 15, 2004; 173(8): 5036 - 5045. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakamura, A. Malykhin, and K. M. Coggeshall The Src homology 2 domain-containing inositol 5-phosphatase negatively regulates Fcgamma receptor-mediated phagocytosis through immunoreceptor tyrosine-based activation motif-bearing phagocytic receptors Blood, October 16, 2002; 100(9): 3374 - 3382. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tridandapani, Y. Wang, C. B. Marsh, and C. L. Anderson Src Homology 2 Domain-Containing Inositol Polyphosphate Phosphatase Regulates NF-{kappa}B-Mediated Gene Transcription by Phagocytic Fc{gamma}Rs in Human Myeloid Cells J. Immunol., October 15, 2002; 169(8): 4370 - 4378. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishihara, T. Sasaoka, M. Ishiki, T. Wada, H. Hori, S. Kagawa, and M. Kobayashi Membrane Localization of Src Homology 2-Containing Inositol 5'-Phosphatase 2 via Shc Association Is Required for the Negative Regulation of Insulin Signaling in Rat1 Fibroblasts Overexpressing Insulin Receptors Mol. Endocrinol., October 1, 2002; 16(10): 2371 - 2381. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Leitges, K. Gimborn, W. Elis, J. Kalesnikoff, M. R. Hughes, G. Krystal, and M. Huber Protein Kinase C-{delta} Is a Negative Regulator of Antigen-Induced Mast Cell Degranulation Mol. Cell. Biol., June 15, 2002; 22(12): 3970 - 3980. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Phee, W. Rodgers, and K. M. Coggeshall Visualization of Negative Signaling in B Cells by Quantitative Confocal Microscopy Mol. Cell. Biol., December 15, 2001; 21(24): 8615 - 8625. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Damen, M. D. Ware, J. Kalesnikoff, M. R. Hughes, and G. Krystal SHIP's C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation Bloo |